NCT02407704View on ClinicalTrials.gov

A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

December 31, 2016

Conditions
DepressionDepressive Disorder, MajorDepressive DisorderUnipolar DepressionMajor Depressive Disorder
Interventions
DRUG

Venlafaxine XR

OTHER

Aerobic Exercise

DRUG

Lorazepam

Lorazepam may be used in the study for patients who either are already on this drug or who need it for sleep and/or anxiety. Patients taking another benzodiazepine will be asked to convert from their current benzodiazepine to an equivalent dose of Lorazepam (2mg or less in 24 hours). This will be administered in pill form.

Trial Locations (1)

15213

University of Pittsburgh, Pittsburgh

All Listed Sponsors
lead

Kirk Erickson, PhD

OTHER

NCT02407704 - A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise | Biotech Hunter | Biotech Hunter